The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion
Use of preimplantation genetic testing for aneuploidy (PGT-A) in select patients undergoing in vitro fertilization has been theorized to allow for higher live-birth rates when increased elective single-embryo transfer is used. PGT-A testing reliability has recently come under scrutiny. The impact of mosaicism on testing re- liability and embryo damage from the biopsy still need to be determined.
Volume 109, Issue 3, Pages 429–436
Authors:
Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology
Abstract:
The value of preimplantation genetic testing for aneuploidy (PGT-A) as a screening test for in vitro fertilization (IVF) patients has yet to be determined. Several studies demonstrate higher birth rates after aneuploidy testing and elective single-embryo transfer (eSET), suggesting the potential for this testing to decrease the risk of multiple gestations, though these studies have important limitations.
No comments yet.